Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group
- PMID: 11248812
- DOI: 10.1097/00003226-200103000-00001
Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group
Abstract
Purpose: Determinants of the natural history of recurrent herpes simplex virus (HSV) keratitis have not been consistently established. We assessed how previous HSV eye disease affects the risk of recurrent HSV keratitis and evaluated whether demographic and other variables play any predictive role.
Methods: Three hundred forty-six patients in the placebo group of the Herpetic Eye Disease Study's Acyclovir Prevention Trial who had experienced an episode of HSV eye disease in the previous year were followed up for 18 months. Recurrences were categorized according to the type of involvement. Relative rates of recurrence were compared for categories of demographic variables, types and number of previous ocular HSV episodes, previous nonocular HSV infection, and month of the year.
Results: Fifty-eight (18%) of the 346 patients developed epithelial keratitis and 59 (18%) developed stromal keratitis during the 18 months of follow-up. Previous epithelial keratitis did not significantly affect the risk of epithelial keratitis (p = 0.84). In contrast, previous stromal keratitis increased the risk of stromal keratitis 10-fold (p < 0.001), and the risk was strongly related to the number of previous episodes (p < 0.001). Age, gender, ethnicity, and nonocular herpes were not significantly associated with recurrences, and no seasonal effects were observed.
Conclusion: Among patients who experienced active ocular HSV disease in the previous year, a history of epithelial keratitis was not a risk factor for recurrent epithelial keratitis. In contrast, previous, especially multiple, episodes of stromal keratitis markedly increased the probability of subsequent stromal keratitis.
Similar articles
-
Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.Arch Ophthalmol. 2000 Aug;118(8):1030-6. Arch Ophthalmol. 2000. PMID: 10922194 Clinical Trial.
-
Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.N Engl J Med. 1998 Jul 30;339(5):300-6. doi: 10.1056/NEJM199807303390503. N Engl J Med. 1998. PMID: 9696640 Clinical Trial.
-
Herpes simplex virus keratitis in children.Am J Ophthalmol. 2004 Sep;138(3):474-5. doi: 10.1016/j.ajo.2004.04.027. Am J Ophthalmol. 2004. PMID: 15364233 Review.
-
A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group.Arch Ophthalmol. 1997 Jun;115(6):703-12. doi: 10.1001/archopht.1997.01100150705001. Arch Ophthalmol. 1997. PMID: 9194719 Clinical Trial.
-
The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections.Curr Opin Ophthalmol. 1999 Aug;10(4):230-3. doi: 10.1097/00055735-199908000-00002. Curr Opin Ophthalmol. 1999. PMID: 10621528 Review.
Cited by
-
Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection.Indian J Ophthalmol. 2018 May;66(5):697-699. doi: 10.4103/ijo.IJO_904_17. Indian J Ophthalmol. 2018. PMID: 29676321 Free PMC article.
-
Ocular herpes simplex.BMJ Clin Evid. 2008 Jul 23;2008:0707. BMJ Clin Evid. 2008. PMID: 19445742 Free PMC article.
-
Reactivation of herpes simplex viral keratitis following the botulinum toxin injection.Indian J Ophthalmol. 2018 Feb;66(2):306-308. doi: 10.4103/ijo.IJO_714_17. Indian J Ophthalmol. 2018. PMID: 29380788 Free PMC article.
-
Adoption of Innovation in Herpes Simplex Virus Keratitis.Cornea. 2020 Nov;39 Suppl 1(1):S7-S18. doi: 10.1097/ICO.0000000000002425. Cornea. 2020. PMID: 32732703 Free PMC article. Review.
-
Herpes simplex keratitis in central India: Clinical types, treatment patterns, and outcome measures.Indian J Ophthalmol. 2025 Jul 1;73(7):1050-1054. doi: 10.4103/IJO.IJO_2233_24. Epub 2025 Jun 30. Indian J Ophthalmol. 2025. PMID: 40586190 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources